Acurx Pharmaceuticals ACXP Cash Flow Statement (2020-2026)

NASDAQ ACXP
$1.45 +0.01 (+0.69%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-4.12M-2.82M-2.94M-2.15M-2.25M-1.99M-1.58M-1.68M-2.25M
Share-based Compensation (Quarter)
1.89M0.76M0.02M0.02M0.70M0.73M0.02M0.11M0.83M0.89M0.11M0.02M0.35M0.33M0.00M0.18M0.29M0.69M0.72M
Cash from Operations (Quarter)
-2.64M-1.50M-1.88M-1.99M-2.18M-1.50M-1.93M-1.58M-2.09M-4.20M-3.06M-2.88M-2.19M-2.25M-2.05M-1.67M-1.88M-1.18M-1.41M-1.71M
Change in Working Capital
Change in Receivables (Quarter)
-0.13M0.05M0.05M-0.05M-0.05M0.04M0.01M0.01M0.04M
Change in Accured Expenses (Quarter)
-1.21M0.13M-0.21M-0.16M0.71M0.88M0.01M0.95M0.20M-0.18M0.07M0.04M0.17M-0.08M-0.34M0.10M-0.12M-0.05M0.11M0.31M
Financing Activities
Other financing activities (Quarter)
0.21M
Change in Capital Stock
Shares Issued (Quarter)
1.57M2.36M1.34M1.21M1.06M2.47M1.71M1.90M2.09M2.98M2.49M3.88M3.88M0.19M3.79M0.23M0.23M0.23M0.21M0.35M
Net Equity Issued and Repurchased (Quarter)
-1.001.60M2.80M3.13M0.85M
Misc.
Cash from Financing Activities (Quarter)
-1.004.62M4.51M0.32M1.59M0.19M2.99M3.09M1.72M2.83M3.11M3.11M
Change in Cash (Quarter)
-2.64M-1.50M-1.88M-1.99M1.52M-1.50M-1.93M1.97M-2.09M0.42M1.45M-2.56M-0.60M-2.06M0.94M1.42M-0.16M1.65M1.70M1.40M
Free Cash Flow (Quarter)
-2.64M-1.50M-1.88M-1.99M-2.18M-1.50M-1.93M-1.58M-2.09M-4.20M-3.06M-2.88M-2.19M-2.25M-2.05M-1.67M-1.88M-1.18M-1.41M-1.71M
Net Cash Flow (Quarter)
-2.64M-1.50M-1.88M-1.99M-2.18M-1.50M-1.93M-1.58M-2.09M0.42M1.45M-2.56M-0.60M-2.06M0.94M1.42M-0.16M1.65M1.70M1.40M